Clinical Trials
101 trialsBrightline-1: A Study to Compare Brigimadlin (BI 907828) With Doxorubicin in People With a Type of Cancer Called Dedifferentiated Liposarcoma
Boehringer Ingelheim
SKYSCRAPER-06
Hoffmann-La Roche
Extension Study Investigating the Long-Term Safety of Degarelix One-Month Depots in Patients With Prostate Cancer
Ferring Pharmaceuticals
Study of Sitravatinib With or Without Other Anticancer Therapies Receiving Clinical Benefit From Parent Study
Mirati Therapeutics Inc.
GuideView
Novartis
BM
Alpha Biopharma (Jiangsu) Co., Ltd.
D-0316 Versus Icotinib in Patients With Locally Advanced or Metastatic EGFR Sensitising Mutation Positive NSCLC
Betta Pharmaceuticals Co., Ltd.
B-MIND
Incyte Corporation
MAHOGANY
MacroGenics
PG2 Treatment for Improving Fatigue Among Advanced Cancer Patients Under Standard Palliative Care
PhytoHealth Corporation
Study of B013 and Nab-Paclitaxel for Locally Advanced or Metastatic Triple Negative Breast Cancer
Shanghai Jiaolian Drug Research and Development Co., Ltd
NICE
Eurofarma Laboratorios S.A.
A Study of JNJ-63723283, an Anti-programmed Death-1 Monoclonal Antibody, Administered in Combination With Daratumumab, Compared With Daratumumab Alone in Participants With Relapsed or Refractory Multiple Myeloma
Janssen Research & Development, LLC
MOUNTAINEER-02
Seagen Inc.
Timolol Maleate Gel for the Treatment of Infantile Hemangioma
Auson Pharmaceuticals Inc.
Study of Tozuleristide and the Canvas Imaging System in Pediatric Subjects With CNS Tumors Undergoing Surgery
Blaze Bioscience Inc.
Prevent
AlloVir
Study of ONO-4538 in Gastric Cancer
Ono Pharmaceutical Co., Ltd.
NEUGR-002
Teva Branded Pharmaceutical Products R&D, Inc.
HuMax-CD4 in Non-Cutaneous T-Cell Lymphoma
Emergent BioSolutions
DENIM
Amphera BV
CheckMate 9X8
Bristol-Myers Squibb
An Open-Label Study of JZP-458 (RC-P) in Patients With Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL)
Jazz Pharmaceuticals
ATOMIC
Polaris Group
Dose-Ranging Efficacy and Safety Study of Topical Rapamycin Cream for Facial Angiofibroma Associated With Tuberous Sclerosis Complex
Dermatology Specialties Limited Partnership
Safety, Efficacy and Pharmacokinetics of an Antifungal in Patients Undergoing Chemotherapy
Basilea Pharmaceutica
Study to Investigate Safety, Efficacy of an Anti-IFNγ mAb in Children With Primary Haemophagocytic Lymphohistiocytosis
Swedish Orphan Biovitrum
SEAL
Karyopharm Therapeutics Inc
Trial to Compare the Efficacy and Safety Of MW05 and PEG-rhG-CSF
Mabwell (Shanghai) Bioscience Co., Ltd.
FORT-1
Bayer
GRASPIVOTALL
ERYtech Pharma
MK-3475-010
Merck Sharp & Dohme LLC
OSPREY
Progenics Pharmaceuticals, Inc.
NBTXR3 Crystalline Nanoparticles and Radiation Therapy in Treating Randomized Patients in Two Arms With Soft Tissue Sarcoma of the Extremity and Trunk Wall
Nanobiotix
Study to Evaluate Safety and Efficacy of Blinatumomab in Subjects With Relapsed/Refractory (R/R) Aggressive B-Cell NHL
Amgen
Dinutuximab and Irinotecan Versus Irinotecan to Treat Subjects With Relapsed or Refractory Small Cell Lung Cancer
United Therapeutics
Masitinib in Combination With Gemcitabine in Advanced/Metastatic Epithelial Ovarian Cancer Patients
AB Science
Masitinib in Combination With FOLFIRI in Third or Fourth Line of Treatment of Patients With Metastatic Colorectal Cancer
AB Science
Evaluation of Clinical Efficacy and Safety of Nuvastatic in Cancer Asthenia
Natureceuticals Sdn Bhd
SPARK-AML1
AstraZeneca
Study of Lenalidomide to Evaluate Safety and Effectiveness in Patients With Diffuse Large B-Cell Lymphoma (DLBCL)
Celgene
Thalidomide 100 mg/Day Versus Thalidomide 400 mg/Day in Relapse Refractory Multiple Myeloma
Celgene
Safety and Efficacy of Etanercept (Recombinant Human Tumor Necrosis Factor Receptor Fusion Protein [TNFR:Fc]) in Children With Juvenile Rheumatoid Arthritis (JRA)
Amgen
ALTER0703
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Study of Anlotinib in Patients With Medullary Thyroid Carcinoma(ALTER01031)
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
A Study to Evaluate Two Concentrations of DFD-07 Cream, in Subjects With Actinic Keratosis (AK) of the Face and/or Scalp Over a 12-week Treatment Period
Dr. Reddy's Laboratories Limited
CRC009
Shanghai Zhangjiang Biotechnology Limited Company
An Efficacy and Safety Study of Decitabine (DACOGEN) Plus Talacotuzumab (JNJ-56022473; Anti CD123) Versus Decitabine (DACOGEN) Alone in Participants With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy
Janssen Research & Development, LLC
tnAcity
Celgene
Evaluation of the Mixture Myoinositol:D-chiro-inositol 3.6:1 in Women With Polycystic Ovary Syndrome
Biosearch S.A.